The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
|Articles|December 2, 2013
- Pharmaceutical Technology-12-02-2013
- Volume 37
- Issue 12
Tablet Tooling Coating Reduces Formulation Sticking
Author(s)Melanie Sena
Tablet Tooling Coating Reduces Formulation Sticking
PharmaCote CX and CX+, an enhanced Chromium Nitride, are a range of coatings developed to improve the performance of substrate material for punches and dies. The coating offers a smooth finish and anti-stick performance, the company reports. PharmaCote CX provides prolonged tooling life due to a multi-layered application. It also offers up to 13 times more corrosion resistance than PharmaCote HC (Hard Chromium) and up to two times the life of PharmaCote CN (Chromium Nitride).
Articles in this issue
almost 13 years ago
Rail-Mounted Fluid Bed Dryers Allow Cleaning Accessalmost 13 years ago
Biotechnology Innovation and Growth in Israelalmost 13 years ago
Drug Manufacturing Focus: Why India?almost 13 years ago
Clinical Trials Head East to Asiaalmost 13 years ago
Climate Change in Outsourcingalmost 13 years ago
Deficiencies Found in API Inspectionsalmost 13 years ago
Q&A with Brian Galliher, Cook Pharmicaalmost 13 years ago
Inspiring the Next Generationalmost 13 years ago
Establishing a Minimum Incubation Time for Biological IndicatorsRelated to this article
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
PharmTech AI Pulse Check: Fixing AI Slop at the Source
4
Inluriyo-Verzenio Combo Doubles PFS, Adds Oral Complexity
5